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To examine the association between sleep disorders, obesity status, and the risk of diabetes in adults, a total of 3668 individuals aged
40+ years from theNHANES 2009-2010 withoutmissing information on sleep-related questions, measurements related to diabetes,
and BMI were included in this analysis. Subjects were categorized into three sleep groups based on two sleep questions: (a) no sleep
problems; (b) sleep disturbance; and (c) sleep disorder. Diabetes was defined as having one of a diagnosis from a physician; an
overnight fasting glucose > 125 mg/dL; Glycohemoglobin > 6.4%; or an oral glucose tolerance test > 199mg/dL. Overall, 19% of
subjects were diabetics, 37% were obese, and 32% had either sleep disturbance or sleep disorder. Using multiple logistic regression
models adjusting for covariates without including BMI, the odds ratios (OR, (95% CI)) of diabetes were 1.40 (1.06, 1.84) and 2.04
(1.40, 2.95) for those with sleep disturbance and with sleep disorder, respectively. When further adjusting for BMI, the ORs were
similar for those with sleep disturbance 1.36 (1.06, 1.73) but greatly attenuated for those with sleep disorders (1.38 [0.95, 2.00]). In
conclusion, the impact of sleep disorders on diabetes may be explained through the individuals’ obesity status.
1. Introduction
Over the past two decades, a dramatic increase in prevalence
of obesity has been witnessed globally. As the result, the
incidence and prevalence rates of type 2 diabetes (T2D)
have also been elevated significantly. In the United States,
it has been estimated that currently approximately a third
of adults are obese (defined as BMI ≥ 30 kg/m2) [1], and
over 11% of people aged 20 years and older have diabetes
[2]. Among those who are obese, approximately 60% have
T2D [3]. The increasingly common early onset of T2D is
not surprising as more children become overweight and
obese [4]. The precise mechanisms linking obesity status and
T2D remain unclear, but the progress of insulin resistance
is considered as the key to this link [5]. Sleep problems are
common among those obese subjects who are at a great risk
for developing T2D [6].The emerging evidence indicates that
sleep-related problems may play a role in the development of
these concurrent illnesses [7]. A clear understanding of the
interrelationships between sleep-related problems, obesity,
and T2Dmay provide information that would allow effective
strategies for prevention and/or intervention of these two
diseases. In this report, the National Health and Nutrition
Examination Survey (NHANES) 2009-2010 data was used to
examine the associations between sleep status, obesity status,
and T2D.
2. Methods
2.1. NHANES 2009-2010 and Its Participants. The NHANES
2009-2010 is a stratified, multistage probability design survey
conducted between 2009 and 2010 with approximately 10,500
people aged 0 year and over being involved. Details of the
survey design and measurement procedures can be found
elsewhere [8]. We restricted our sample to those whose age
was 40 years and older since T2D is the most common
type of diabetes mellitus among adults and diabetes among
individuals aged 40 and above is most likely T2D. A total
of 4,009 subjects aged 40 years and older were identified
2 International Journal of Endocrinology
in the NHANES 2009-2010 data set. After removing indi-
viduals with missing information on sleep-related questions,
variables related to diabetes, body mass index, and pregnant
women, a total of 3,668 individuals (1,813 men and 1,855
women) were included in this analysis.
2.2. Sleep Disorders Measurements. Three sleep-related ques-
tions were asked, in the home, by trained interviewers
using the Computer-Assisted Personal Interviewing (CAPI)
system. They are “how much sleep do you usually get at
night on weekdays or workdays?” “Have you ever told a
doctor or other health professionals that you have trouble
sleeping?” and “Have you ever been told by a doctor or other
health professional that you have a sleep disorder?” The first
question was measured by hours in sleep and the other two
questions as “yes” versus “no” responses. Using the last two
questions, all subjects were grouped into three categories;
that is, group one, no sleep problems if the answers for both
questions were “no”; group two, having a sleep disturbance
if “yes” to the first question, but “no” to the second question;
and group three, having a sleep disorder if “yes” to the second
question. Since it has been suggested that either shorter sleep
hours or longer sleep hours are associated with the increased
risk for cardiovascular disease [9], sleeping hour responses
are also categorized into three groups <7, 7-8, and >8 hours.
2.3. Body Mass Index Related Measurements. Body mass
index (BMI) was derived from body weight and standing
height and was used to determine obesity status of the
participants in the survey. Both weight and height are part
of body measurements, which were measured in the Mobile
Examination Center (MEC), by trained health technicians
following the 2009-2010 NHANES anthropometry protocol
[10]. Participants wore the standardMEC examination gown,
which consists of a disposable shirt, pants, and slippers.
Weight was measured using a digital weight scale and
measured to near 0.1 kg. Standing height was measured using
a stadiometer and measured to 0.1 cm. BMI was calculated
as weight (kg) divided by the square of their standing height
(m2) and then categorized into three groups, that is, BMI <
25.0 kg/m2, BMI: 25.0–29.9 kg/m2, and BMI ≥ 30.0 kg/m2.
The last two groups were considered as overweight and
obese, respectively [11]. There are 95 subjects (51 men and
44 women), about 2.6% of the study sample, whose BMI
were below 18.5 kg/m2, which is considered as underweight
[12]. Similar results are found when excluding these subjects;
therefore, we reported our results with them included.
2.4. Diabetes Mellitus Related Measurements. Diabetes melli-
tus is defined as either having been diagnosed with diabetes
mellitus by a physician, or a fasting glucose level >125mg/dL
(6.9mmol/L), or a 2-hour value in the oral glucose tol-
erance test (OGTT) >199mg/dL (11.1mmol/L), or HbA1C
level ≥6.5% [13]. Blood was drawn at the MEC, and blood
specimens were processed, stored, and shipped to Fairview
Medical Center Laboratory at the University of Minnesota,
Minneapolis Minnesota for analysis. The concentration of
glucose was measured using enzymatic method, and the
level of HbA1C was measured using G7 Glycohemoglobin
Analyzer [14]. Diabetes mellitus was the main outcome and
was coded as 1 = yes and 0 = no in the analysis.
2.5. Measurements of Covariates. Covariates in the analysis
included age (years), gender (male versus female), ethnicity
(non-Hispanic white versus others), education (less than
high-school versus high-school or higher), marital status
(livingwith a spouse or partner: yes versus no), ratio of family
income to poverty threshold, currently cigarette smoking
(yes versus no), alcohol drinking (average drinks per day),
sedentary activity time per day (minutes), total to HDL
cholesterol ratio, systolic blood pressure (mmHg), and C-
reactive protein (mg/dL).
2.6. Statistical Analysis. All analyses were conducted using
survey procedures in SAS 9.3 (SAS Institute Inc., Cary, NC,
USA), and take into account the weighted and clustered sam-
pling design of NHANES.The significant level was defined at
2-tailed alpha equal or less than 0.05. Odds ratio (OR) and its
95% confidence interval (CI) from logistic regression models
were used to examine the relationship between diabetes and
sleep disorder status, and four models have been used for
this purpose. Diabetes mellitus is the dependent variable in
each model, and two indicator variables were created for
people having a sleep disturbance and having a sleep disor-
der, respectively. Subjects who reported no sleep issues are
considered as the reference in the analyses. The covariates in
Model One were age, gender, race, education, ratio of family
income to poverty, and marital status; in Model Two were
the covariates in Model One plus total to HDL cholesterol
ratio, systolic blood pressure, sedentary active time, alcohol
drinking, and cigarette smoking; in Model Three were the
covariates in Model Two plus C-reactive protein and sleep
duration; and in Model Four, BMI was added to the analysis.
To examine the impact of interaction of sleep disorder
and obesity status on diabetes mellitus, we further created
eight indictors to indicate people’s sleep disorder and obesity
status, that is, (1) reporting a sleep disturbance and BMI <
25.0 kg/m2; (2) reporting a sleep disorder and BMI <
25.0 kg/m2; (3) reporting no sleep problems and BMI: 25.0–
29.9 kg/m2; (4) reporting a sleep disturbance and BMI: 25.0–
29.9 kg/m2; (5) reporting a sleep disorder and BMI: 25.0–
29.9 kg/m2; (6) reporting no sleep problem and BMI ≥
30.0 kg/m2; (7) reporting a sleep disturbance and BMI ≥
30 kg/m2; and (8) reporting a sleep disorder and BMI ≥
30 kg/m2. Those people reporting no sleep issues and BMI <
25 kg/m2 were used as the reference, and all covariates in the
Model Three in previous analyses were included.
3. Results
Approximately 19% individuals in this sample were catego-
rized as diabetes mellitus. The prevalence rates of having
sleep disturbance and sleep disorder were 22.1% and 9.4%,
respectively. Based on BMI measurements, approximately
35% of people were in the overweight group and 37% were in
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Figure 1: The ORs of diabetes by different combinations of sleep and obesity status after adjustment for age, gender, race, education,
ratio of family income to poverty, marital status, total to HDL cholesterol ratio, systolic blood pressure, sedentary activity time, alcohol
drinking, cigarette smoking, C-reactive protein, and sleep duration. The group of BMI < 25.0 with no sleep problem is the reference group.
+
𝑃 value <0.05.
obese group. Characteristics of participants by sleep disorder
status are shown in Table 1. Compared to people without
sleep problem, individuals with sleep disturbance had similar
profiles apart from being more likely to be female, non-
Hispanic white, less likely to live with a spouse or partner,
having a higher level of C-reactive protein, and shorter
sleep duration. Those having sleep disorder were statistically
different from those without sleep problems except for age,
ratio of family income to poverty, lifestyle variables, total
to HDL cholesterol ratio, blood pressure measurements, and
percentage male.
The ORs and their 95% CIs derived from logistic regres-
sion models are presented in Table 2. The odds of diabetes
for the first three models are similar. Compared to those
having no sleep problem, the ORs of diabetes in ModelThree
for those with a sleep disturbance and those with a sleep
disorder were 1.40 (95%CI: 1.06, 1.84) and 2.04 (95%CI:
1.40, 2.95), respectively. When further adjusting for BMI in
Model Four, theOR for those with a sleep disturbance did not
change much (OR (95%CI): 1.36 (1.06, 1.73)) but was greatly
attenuated for those having a sleep disorder (1.38 (0.95, 2.00)).
Figure 1 shows the ORs of diabetes for different combi-
nations of sleep and obesity status. After adjustment for all
covariates used in Model three in the previous analysis and
using those reporting no sleep problems and BMI < 25 kg/m2
as the referent group, the odds of diabetes for those with a
sleep disturbance or a sleep disorder were similar if their BMI
was <25 kg/m2. The ORs (95%CIs) of T2D for sleep distur-
bance and sleep disorder were 1.32(0.69, 2.49) and 0.75 (0.28,
1.99), respectively, when they were in the group of BMI <
25 kg/m2. The ORs (95%CIs) for those with BMI: 25.0–
29.9 kg/m2 were 1.58 (1.16, 2.15) in the group of reporting
no sleep problem, 2.30 (1.37, 3.86) in the group of reporting
a sleep disturbance, and 1.24 (0.57, 2.68) in the group of
reporting a sleep disorder.While the ORs (95%CIs) for those
with a BMI ≥ 30 kg/m2 were 4.08 (2.59, 6.41), 5.88 (3.53, 9.80),
and 8.33 (4.81, 14.49) for those in the groups of reporting
no sleep problem, a sleep disturbance, and a sleep disorder,
respectively.
To confirm that the results from the previous analyses
were not due to the change of the sample size from model to
model, we used a multiple imputationmethod [15] to create a
database with all missing values imputed, and the results are
similar (data not shown).
4. Discussion
Although evidence indicates that sleep problems increase the
risk of cardiovascular disease (CVD) [16–18], and a similar
risk association has been observed between sleep problems
and diabetesmellitus [19–21], it is unclear whether the impact
of sleep problems on T2D may be mediated through obesity.
Because sleep disorders are prevalent among people with
overweight and obesity, which is also a risk for T2D [22–
24]; when examining the risk association of T2D with sleep
problems in cohort studies, researchers previously took into
account the impact of BMI measured at baseline [25–28].
Yet, the results from these cohort studies are not consistent.
For instance, a cohort of women from Gothenburg, Sweden,
were followed for 32 years, and no significant associations or
trends were observed between incidence of diabetes and any
of the available sleep indicators; however, obesity status, using
either BMI orwaist circumference, was highly associatedwith
sleep problems [26].The results from theNursesHealth Study
suggested that sleep restriction might mediate the effect of
weight change on diabetes mellitus [25]. However to date, no
study has closely examined these associations. Using recent
NHANES data, we explored this issue and found that people
with sleep disorders are indeed associated with a great risk of
diabetesmellitus independently fromanumber of known risk
factors without including BMI. However, after taking BMI
into account the odds ratio of diabetes mellitus is similar for
those with sleep disturbance but significantly attenuated for
those with sleep disorders. This suggests that the impact of
sleep disorders on diabetes mellitus may be confounded by
BMI. Results from the model with different combinations of
sleep and obesity status (Figure 1) further demonstrate that
the risk association of diabetes mellitus with sleep disorders
may be mediated through obese status. Subjects not in the
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Table 1: Basic characteristics of 3668 participants in the NHANES 2009-2010 by sleep disorder status.
None Sleep disturbance Sleep disorders
𝑛 2551 773 344
Demographic measures
Age (yrs, mean [S.E.]) 57.9 [0.3] 58.2 [0.7] 56.9 [0.7]
Male (%) 50.5 37.3∧ 51.5
Non-Hispanic white (%) 72.1 79.9∧ 76.3∧
Less than high school (%) 20.9 19.6 17.6∧
Living with spouse or partner (%) 70.9 63.2∧ 61.3∧
Ratio of family income to poverty (mean [S.E.]) 3.23 [0.04] 3.17 [0.09] 3.1 [0.14]
Cigarette smoking (%) 14.4 15.6 14.9
Alcohol drinking (average drinks/day, mean (S.E.]) 1.9 [0.4] 1.4 [0.1] 1.5 [0.14]
Body composition measures
Body mass index (kg/m2, mean [S.E.]) 28.5 [0.2] 29.3 [0.3] 32.9 [0.5]∧
Waist circumference (cm, mean [S.E.]) 99.2 [0.5] 100.8 [0.8] 109.4 [1.3]∧
Measurements from blood sample
Total to HDL cholesterol ratio (mean [S.E.]) 4.06 [0.03] 4.0 [0.06] 4.1 [0.11]
C-reactive protein (mg/dL, mean [S.E.]) 0.33 [0.01] 0.51 [0.06]∧ 0.54 [0.06]∧
Glycohemoglobin (%, mean [S.E.]) 5.77 [0.03] 5.86 [0.04] 5.98 [0.06]∧
Blood pressure and pulse measures
Systolic blood pressure (mmHg, mean [S.E.]) 124.7 [0.6] 125.1 [0.9] 125.0 [1.3]
Diastolic blood pressure (mmHg, mean [S.E.]) 70.1 [0.7] 69.8 [0.7] 69.8 [1.3]
Sedentary activity (min, mean [S.E.]) 336.4 [6.0] 351.9 [10.7] 389.9 [11.6]∧
Sleep duration (hours, mean [S.E.]) 7.09 [0.03] 6.51 [0.08]∧ 6.54 [0.11]∧
Diabetes (%) 17.1 20.9 27.2∧
∧
𝑃 < 0.05 when compared to “none.”
Table 2: Adjusted odds ratio of diabetes for sleep disorder status, NHANES 2009-2010.
𝑁 None OR (95% confidence interval)
With a sleep disturbance With a sleep disorder
Model 1 3300 1.00 1.43 (1.07, 1.89) 2.08 (1.39, 3.09)
Model 2 3188 1.00 1.44 (1.05, 1.99) 2.14 (1.44, 3.17)
Model 3 3185 1.00 1.40 (1.06, 1.84) 2.04 (1.40, 2.95)
Model 4 3148 1.00 1.36 (1.06, 1.73) 1.38 (0.95, 2.00)
Model 1: adjustment for age, gender, race, education, ratio of family income to poverty, and marital status.
Model 2: further adjustment for total to HDL cholesterol ratio, systolic blood pressure, sedentary activity time, alcohol drinking, and cigarette smoking.
Model 3: further adjustment for C-reactive protein and sleep duration.
Model 4: further adjustment for BMI.
overweight or obese groups but having a sleep disturbance
or disorder had similar odds for diabetes mellitus as those
with no sleep problems. However, for those in the overweight
group (BMI: 25–29.9 kg/m2), the odds of T2D are higher
regardless of their sleep status, while those in the obese group
had over four folds higher odds of T2D and those with a sleep
disorder had the highest one.
Laboratory studies conducted among healthy adults have
shown that short-term sleep deprivation could increase each
of insulin resistance, sympathetic tone, blood pressure, and
C-reactive protein level [29–31]. Observational studies have
reported that children with sleep problems are more likely
to be overweight and obese [32, 33]. It appears that having
a healthy weight through exercise may be the key variable
in both overweight/obesity prevention and intervention [34]
and that the preschool years are a key time for shaping
relevant attitudes and behaviours [35]. As physical activity
also has a positive effect on sleep pattern, its benefits may
go beyond simple weight control [36, 37]. Although in
this report, we cannot test the role of physical activity on
the association between sleep disorders, obesity status, and
diabetes mellitus, the significantly longer sedentary time
among those individuals with sleep disorders in comparison
to those reporting no sleep problems suggests that physical
activity is a critical element for intervention.
Compared to waist circumference, BMI has been criti-
cized for not being a good indicator of central obesity in the
risk prediction of cardiovascular disease [38]. Central obesity
is a prevalent trait among people with sleep disorders, but
results from a meta-analysis indicated that both BMI and
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waist circumference are similarly associated with the risk of
diabetes since they are highly correlated to each other [39].
The Pearson correlation coefficient between the body mass
index and waist circumference in our data is 0.9, and the
replacement of BMI with waist circumference in the Model
4 shows similar results—ORs (95%CI) of diabetes for sleep
disturbance and sleep disorders are 1.31 (1.01, 1.68) and 1.28
(0.88, 1.85), respectively. This suggests that the impact of
sleep problems on diabetes is indeed affected by individual’s
obesity status though different sleep problems show different
interactions.
Several limitationsmust be recognized when interpreting
the results of this study. First, this was a cross-sectional study,
and therefore conclusions about causal associations cannot be
made. Second, the sleep-related problems were self-reported
and may not reflect the true picture of sleep status. However,
the results from a study indicate that self-reported sleep
duration was relatively accurate [40]. The “yes/no” questions
on whether one has reported having trouble sleeping to a
physician or whether a physician has told the person that
he or she has a sleep disorder are quite straightforward
and should be reliable. Third, we did not control for the
impact of physical activity in this study, but we did control
for the self-reported sedentary activity time, which may be
underreported due to a social desirability bias. However, we
assume that this underreported time is random and should
not differ with different sleep status. The strengths of this
study are (1) the data are from a well-designed nationally
representative survey; (2) the laboratory measurements are
validated and reliable; and (3) we have adjusted for a number
of known risk factors including sleeping duration.
In conclusion, sleep disturbance is independently associ-
ated with an increased risk for T2D. However, the impact of
sleep disorders on T2D may be explained by obesity status.
Longitudinal research is needed to examine the relationship
between sleep problems, changes in obesity status, and their
impacts on the development of T2D.
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